Matthias Kromayer
Director Ejecutivo en Tavia Consulting GmbH .
Origen de la red de primer grado Matthias Kromayer.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 12 | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX.
11
| Subsidiary | Biotechnology | 11 |
MIG Verwaltungs AG
 MIG Verwaltungs AG Investment ManagersFinance MIG Verwaltungs AG is a private equity investment firm headquartered in Munich, Germany. It was founded in 2004 by entrepreneurs and financial institutions, to follow up on the success of the venture capital investment vehicles Global Chance Fund and Global Asset Fund, with which MIG's management had been involved.
9
| Subsidiary | Investment Managers | 9 |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany.
8
| Holding Company | Biotechnology | 8 |
BIOCRATES Life Sciences AG
 BIOCRATES Life Sciences AG BiotechnologyHealth Technology BIOCRATES Life Sciences AG operates as a research and technology. It provides metabolic phenotyping services. The firm products are absoluteIDQ p150 kit, p180 kit, sterio17 kit, steroid reagents, biocrates bile acids kit, and steroid kit. The company was founded by Gunther Bonn, Adelbert Roscher, and Hartmut Glossmann in 2002 and is headquartered in Innsbruck, Austria.
4
| Holding Company | Biotechnology | 4 |
Minaris Regenerative Medicine GmbH
 Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology apceth Biopharma GmbH operates as a contract development & manufacturing organization. The firm specializes in cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs). Its GMP services include quality management, quality control, assay development, process development, cell banking & formulation and project management. The company was founded in 2007 and is headquartered in Munich, Germany.
3
| Subsidiary | Biotechnology | 3 |
AMSilk GmbH
 AMSilk GmbH TextilesProcess Industries AMSilk GmbH engages in the production of fiber and biopolymers.It offers implant coating, medical devices for OTC wound care, functional cosmetics, cell biology device kits, biosteel spidersilk fibers and spidersilk research license. It serves the biosteel fibers, medical devices, and cosmetic ingredients industry. The firm's materials are to be applied in numerous fields to improve existing products or to develop materials for completely new applications, which could not be realized until now due to the lack of an appropriate material. The company was founded by Axel H. Leimer, Thomas Scheibel, and Lin Römer in 2008 and is headquartered in Planegg, Germany.
3
| Holding Company | Textiles | 3 |
Ci3 Management UG
2
| Private Company | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Matthias Kromayer a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Founder Director/Board Member Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| IMMATICS N.V. | Biotechnology | Chairman Director/Board Member Director/Board Member Founder Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Eberhard Karls Universität Tübingen | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
APK AG
 APK AG Wholesale DistributorsDistribution Services APK AG provides recovery services of raw materials such as fossil fuels like oil, coal, gas, and renewable resources like plants. It also provides grinding and screening processes for hard rocks. The company was founded by Wolfgang Lindner in 2008 and is headquartered in Merseburg, Germany. | Wholesale Distributors | Chairman Director/Board Member Chairman | |
| Association For Cancer Immunotherapy | President Chairman Corporate Officer/Principal | ||
febit holding GmbH
 febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | Medical/Nursing Services | Director/Board Member Director/Board Member Chairman | |
| BIONTECH SE | Biotechnology | Founder Founder Director/Board Member | |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| University of Münster | College/University | Undergraduate Degree Undergraduate Degree | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer | ||
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of St. Gallen | College/University | Undergraduate Degree Masters Business Admin | |
| University of Freiburg | College/University | Corporate Officer/Principal Graduate Degree | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Febit, Inc. | Director/Board Member Chairman | ||
| Julius-Maximilians-Universität Würzburg | College/University | Doctorate Degree Doctorate Degree | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
FIZ Frankfurter Innovationszentrum Biotechnologie GmbH
 FIZ Frankfurter Innovationszentrum Biotechnologie GmbH Miscellaneous Commercial ServicesCommercial Services FIZ Frankfurter Innovationszentrum Biotechnologie GmbH is a market-oriented small and medium-sized enterprise in the field of life sciences. The company is based in Frankfurt, Germany. The German company provides a unique basis for innovation and growth. The company is ultimately controlled by the State of Hessen. The company was founded in 2002. Christian Garbe has been the CEO of the company since 2002. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Definiens AG
 Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Packaged Software | Chairman Director/Board Member | |
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
| MORPHOSYS AG | Biotechnology | Chairman Corporate Officer/Principal | |
Efficient Energy GmbH
 Efficient Energy GmbH Wholesale DistributorsDistribution Services Efficient Energy GmbH develops and produces cooling plants and heat pumps for industrial and home applications. The company uses only water as a coolant and reduces energy consumption to low levels. The company was founded in September 2006 by Holger Sedlak, Oliver Kniffler, and Wolfgang Jacobi and is headquartered in Feldkirchen, Germany. | Wholesale Distributors | Chairman Chief Executive Officer | |
AFFiRiS AG
 AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | Medical/Nursing Services | Director/Board Member Chairman | |
| University of Kiel | College/University | Doctorate Degree Doctorate Degree | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Director/Board Member Doctorate Degree | |
MP Beteiligungs GmbH
 MP Beteiligungs GmbH Financial ConglomeratesFinance MP Beteiligungs GmbH operates as an investment holding company. The firm’s focus areas encompass asset acquisition and management, investment management, project financing, and business consulting. Its investment and management operations involve businesses engaged in biotechnology research, real estate development and in the manufacture of automotive and aircraft seating. The company is headquartered in Kaiserslautern, Germany. | Financial Conglomerates | Corporate Officer/Principal Chief Executive Officer | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Founder | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Chief Investment Officer | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chief Investment Officer |
Estadísticas
Internacional
| Alemania | 36 |
| Dinamarca | 6 |
| Suiza | 5 |
| Estados Unidos | 5 |
| Austria | 2 |
Sectorial
| Health Technology | 24 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 5 |
| Distribution Services | 3 |
Operativa
| Director/Board Member | 188 |
| Chairman | 89 |
| Chief Executive Officer | 88 |
| Corporate Officer/Principal | 85 |
| Founder | 35 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Christof Hettich | 40 |
| Friedrich von Bohlen und Halbach | 36 |
| Gerald Heinz Möller | 29 |
| Wolfgang Colberg | 24 |
| Peter Chambré | 23 |
| Manfred Rüdiger | 22 |
| Christian Körfgen | 21 |
| Henrijette Richter | 21 |
| Patrick Baeuerle | 19 |
| Harald F. Stock | 17 |
| Klaus Schollmeier | 17 |
| Carsten Reinhardt | 16 |
| Erich Schlick | 15 |
| Georg Kellinghusen | 15 |
| Rainer Strohmenger | 14 |
- Bolsa de valores
- Insiders
- Matthias Kromayer
- Conexiones Empresas
